Info@ThinkPinkRocks.com

Scientists discover genomic alterations in pediatric relapsed ALL

A group of researchers from Columbia University, Rutgers University, and institutions in Europe and Japan have identified genomic alterations in pediatric relapsed acute lymphoblastic leukemia (ALL) that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment.

Read More:
Scientists discover genomic alterations in pediatric relapsed ALL

Share

Leave a Reply